232 related articles for article (PubMed ID: 25155602)
1. Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells.
Sharma BN; Marschall M; Rinaldo CH
Antimicrob Agents Chemother; 2014 Nov; 58(11):6724-34. PubMed ID: 25155602
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Nukuzuma S; Nakamichi K; Kameoka M; Sugiura S; Nukuzuma C; Tasaki T; Takegami T
Microbiol Immunol; 2016 Apr; 60(4):253-60. PubMed ID: 26935240
[TBL] [Abstract][Full Text] [Related]
3. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
4. CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Takegami T
Microbiol Immunol; 2017 Jun; 61(6):232-238. PubMed ID: 28463406
[TBL] [Abstract][Full Text] [Related]
5. Characterization of JC Polyomavirus Derived from COS-IMRb Cells.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Jpn J Infect Dis; 2021 Jan; 74(1):48-53. PubMed ID: 32741932
[TBL] [Abstract][Full Text] [Related]
6. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of artesunate on polyomavirus BK replication in primary human kidney cells.
Sharma BN; Marschall M; Henriksen S; Rinaldo CH
Antimicrob Agents Chemother; 2014; 58(1):279-89. PubMed ID: 24145549
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy-associated mutations in the JC polyomavirus capsid disrupt lactoseries tetrasaccharide c binding.
Maginnis MS; Ströh LJ; Gee GV; O'Hara BA; Derdowski A; Stehle T; Atwood WJ
mBio; 2013 Jun; 4(3):e00247-13. PubMed ID: 23760462
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of JC polyomavirus infectivity by the retrograde transport inhibitor Retro-2.1.
Treasure T; Nelson CDS
Microbiol Immunol; 2020 Dec; 64(12):783-791. PubMed ID: 32965709
[TBL] [Abstract][Full Text] [Related]
10. COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression.
Agostini S; Mancuso R; Costa AS; Guerini FR; Clerici M
Mol Biol Rep; 2020 Nov; 47(11):9201-9205. PubMed ID: 33085050
[TBL] [Abstract][Full Text] [Related]
11. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
12. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of mefloquine efficacy against JC virus in vitro.
Brickelmaier M; Lugovskoy A; Kartikeyan R; Reviriego-Mendoza MM; Allaire N; Simon K; Frisque RJ; Gorelik L
Antimicrob Agents Chemother; 2009 May; 53(5):1840-9. PubMed ID: 19258267
[TBL] [Abstract][Full Text] [Related]
14. JC Polyomavirus Infection Reveals Delayed Progression of the Infectious Cycle in Normal Human Astrocytes.
Wilczek MP; DuShane JK; Armstrong FJ; Maginnis MS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826993
[TBL] [Abstract][Full Text] [Related]
15. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains.
Prezioso C; Passerini S; Limongi D; Palamara AT; Moens U; Pietropaolo V
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146876
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule inhibitors of JC polyomavirus infection.
Yatawara A; Gaidos G; Rupasinghe CN; O'Hara BA; Pellegrini M; Atwood WJ; Mierke DF
J Pept Sci; 2015 Mar; 21(3):236-42. PubMed ID: 25522925
[TBL] [Abstract][Full Text] [Related]
17. A retrograde trafficking inhibitor of ricin and Shiga-like toxins inhibits infection of cells by human and monkey polyomaviruses.
Nelson CD; Carney DW; Derdowski A; Lipovsky A; Gee GV; O'Hara B; Williard P; DiMaio D; Sello JK; Atwood WJ
mBio; 2013 Nov; 4(6):e00729-13. PubMed ID: 24222489
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9.
Chou YY; Krupp A; Kaynor C; Gaudin R; Ma M; Cahir-McFarland E; Kirchhausen T
Sci Rep; 2016 Nov; 6():36921. PubMed ID: 27841295
[TBL] [Abstract][Full Text] [Related]
19. JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab.
Toyoda M; Thomas D; Ahn G; Kahwaji J; Mirocha J; Chu M; Vo A; Suviolahti E; Ge S; Jordan SC
Transpl Infect Dis; 2015 Dec; 17(6):838-47. PubMed ID: 26437369
[TBL] [Abstract][Full Text] [Related]
20. CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes.
Gosert R; Rinaldo CH; Wernli M; Major EO; Hirsch HH
Antimicrob Agents Chemother; 2011 May; 55(5):2129-36. PubMed ID: 21402853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]